Background-There is evidence that patients with chronic obstructive airways disease and asthma who take inhaled steroids have a low bone density. As most of a drug given from a metered dose inhaler is actually swallowed, the possibility that swallowed beclomethasone dipropionate acts topically in the gut to impair calcium absorption was investigated. Such 
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Background-There is evidence that patients with chronic obstructive airways disease and asthma who take inhaled steroids have a low bone density. As most of a drug given from a metered dose inhaler is actually swallowed, the possibility that swallowed beclomethasone dipropionate acts topically in the gut to impair calcium absorption was investigated. Such 10 g butter, 100 g tinned peaches, and 50 ml peach juice.) Subjects had no dairy products with the preceding evening meal, and had no oral intake other Serial 24 hour collections of urine for measurement of calcium, hydroxyproline, and cortisol concentrations were taken throughout days 3 to 7 (week 1), and again during days 11 to 14 (week 2). Twenty four hour urinary cortisol assays were used as a measure of the systemic effect of the swallowed beclomethasone dipropionate. Serum parathyroid hormone, plasma calcium and plasma phosphate concentrations were determined on days 6 and 7 (week 1), and again on days 13 and 14 (week 2).
ANALYTICAL TECHNIQUES
Plasma strontium was assayed by atomic absorption spectrophotometry (coefficient of variation (CV) = 3 5%); serum parathyroid hormone by the mid-molecule radioimmunoassay of Incstar (CV = 16%); plasma calcium and phosphate by Technicon SMAC (CV = 1-6% and 2-6% respectively); urinary hydroxyproline by the spectrophotometric method of Bergman and Loxley23 (CV = 5%); urinary cortisol radioimmunoassay with an Amersham Amerlex kit (CV = 8 2%); and urinary calcium by absorption spectroscopy (CV = 2-1%).
The study was performed with approval of the institute's ethics committee. Statistical analysis was by a two tailed paired t test with Systat 5-2 software.
Results
All 12 subjects finished the study, and all strontium tests were completed. Eighty seven collections of urine and 139 of 144 blood assays were completed. The few failed tests resulted from errors of subject compliance and were not biased to any particular subject group. Subjects did not have side effects during the study. Table 2 shows the results for all assays for all 12 subjects with the beclomethasone dipropionate week compared with the placebo week. Table 3 shows the results for the two separate subject groups of six (placebo to beclomethasone dipropionate and beclomethasone dipropionate to placebo). There was a lower strontium absorption in 11 of 12 subjects during the beclomethasone dipropionate week compared with the placebo week (mean reduction 12%, p < 0-01; fig 1) . There was also a lower mean 24 hour urinary cortisol concentration in 12 subjects during the beclomethasone 2) . In the six subjects proceeding from placebo to beclomethasone dipropionate, there was a mean reduction of 203% in strontium absorption during the second week, with all six subjects having lower strontium absorption when compared with values for the placebo week (p < 0005). In subjects proceeding from beclomethasone dipropionate to placebo, there was a mean increase of 3-2% for strontium absorption in the second (placebo) week, but this was not significant. No other assays showed a significant difference between the beclomethasone dipropionate and placebo weeks, apart from an increased plasma phosphate concentration during the first week of beclomethasone dipropionate ingestion.
Discussion
Inhalation from a metered dose inhaler results in a much greater deposition of topical corticosteroid within the intestine than in the lungs.'0 Topical corticosteroids may have potent actions on mucosal surfaces.24 Within the intestinal lumen, beclomethasone dipropionate is hydrolysed to beclomethasone-17-propionate, which has much greater glucocorticoid receptor affinity.'9 Thus hydrolysis is an important activation step within the intestine, and increases the possibility of a topical effect of the swallowed drug on calcium absorption in the intestine.
The lower strontium absorption during the beclomethasone dipropionate week suggests that intestinal strontium absorption is reduced by beclomethasone dipropionate, as there is no apparent reason for the drug to directly affect strontium clearance. The 203% reduction in strontium absorption in the placebo to beclomethasone dipropionate group was not mirrored by an increase of similar magnitude in the other cross over group (fig 1) . This may be due to an inadequate washout period after beclomethasone dipropionate in the first week. Beclomethasone dipropionate is unaffected by gastric fluid in vitro, and is slowly metabolised to the more potent beclomethasone-17-monopropionate within the The decrease in urinary free cortisol during beclomethasone dipropionate ingestion suggests that a systemic effect of the orally ingested drug occurred despite (a) the weak systemic potency of beclomethasone dipropionate reported in previous studies,'4 and (b) its expected high rate of first pass metabolism when swallowed. Hence, we cannot be sure to what degree the reduction in strontium absorption is topical rather than systemic. Whatever the mechanism, reduction of calcium absorption secondary to beclomethasone dipropionate may be clinically important to bone health, as long term suppression of calcium absorption is known to be associated with parathyroid mediated bone resorption, "7 2529 and low calcium absorption is a major determinant of mineral density loss in vertebral bone.30 Our study assessed the effect of only one week of ingestion, however, and not the effects longer term. The effect of oral corticosteroids on calcium absorption and parathyroid concentrations is sustained,'72829 and therefore a sustained effect remains possible with swallowed beclomethasone dipropionate; this requires further evaluation.
Our study was on normal volunteers but there is no known reason why a suppressive effect on calcium absorption would not also apply to patients with asthma or chronic obstructive airways disease; again further research is needed.
Inhaled corticosteroids affect various indices relevant to bones,3"-34 but a reduction in calcium absorption secondary to treatment with beclomethasone dipropionate has not, to our knowledge, been reported previously.
More research is required to assess the possibility of chronic suppression of calcium absorption in patients rather than healthy volunteers. Effects on other bone indices, particularly bone density, also require further assessement.
